SUBSCRIBE
SUBSCRIBE

Press Releases

Browse the the latest press releases from around the industry. Want to filter press releases by date, keyword, and more? Search here.

THE LATEST
Press Releases
Envoy Medical Announces Pricing of Up to $78.0 Million Upsized Public Offering
$30.0 million upfront with up to an additional $48.0 million of potential aggregate gross proceeds upon the exercise in full of milestone-linked warrants for cash
February 11, 2026
 · 
6 min read
Press Releases
The Agency Worldwide Celebrates Four Decades of Advancing Leadership in Life Sciences Organizations
February 11, 2026
 · 
1 min read
Press Releases
Neurala Biosciences Reports Phase 1 Data Supporting Advancement of Second-Generation DMT–Harmala Candidates NBX-100 and NBX-200
February 11, 2026
 · 
1 min read
Press Releases
Thermo Fisher Scientific Expands Real-World Data Interoperability and Linkage Through Strategic Collaboration with Datavant
February 11, 2026
 · 
3 min read
Press Releases
NashBio Announces Key Leadership Roles, Advancing Technological Enablement and Access to Real-World Data
February 11, 2026
 · 
2 min read
Press Releases
Agilent Presents Boehringer Ingelheim With Inaugural 2025 Instrument Trade‑In Impact Award
February 11, 2026
 · 
2 min read
Press Releases
IntraBio Reports Further Detail on Positive Data from Levacetylleucine Pivotal Trial for the Treatment of Ataxia-Telangiectasia
February 11, 2026
 · 
4 min read
Press Releases
Citius Oncology Expands International Distribution of LYMPHIR™ to European Union Through Exclusive Agreement with Uniphar
February 11, 2026
 · 
10 min read
Press Releases
Ultima Genomics Strengthens Oncology Leadership to Drive Clinical Growth
February 11, 2026
 · 
3 min read
Press Releases
SOFIE Biosciences Announces First Patient Dosed in [18F]FAPI-74 Phase 3 Study for Pancreatic Cancer
February 11, 2026
 · 
3 min read
Press Releases
Crystalys Therapeutics Appoints Tim Walbert, Former Horizon Therapeutics CEO, as Independent Board Director
February 11, 2026
 · 
3 min read
Press Releases
Invitation to Presentations of Senzime’s Q4 and Year-End Report 2025
February 11, 2026
 · 
1 min read
Press Releases
MBX Biosciences to Participate in Upcoming Investor Conferences - February 11, 2026
February 11, 2026
 · 
1 min read
Press Releases
iMDx Announces $26.0 Million Registered Direct Offering
February 11, 2026
 · 
5 min read
Press Releases
Soleno Therapeutics to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026, at 4:30 PM ET
February 11, 2026
 · 
2 min read
Press Releases
Denovo Biopharma Announces Partnership with Orygen on Phase 2 Study Evaluating DB103 (Pomaglumetad Methionil) in Treating Psychosis
February 11, 2026
 · 
3 min read
Press Releases
Amarin to Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 25, 2026
February 11, 2026
 · 
2 min read
Press Releases
Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026
February 11, 2026
 · 
2 min read
Press Releases
VivoSim to Debut Antibody Drug Conjugate Data, representing a major new market for NAMkind models, at Society of Toxicology Meeting in San Diego
February 11, 2026
 · 
4 min read
Press Releases
Candel Therapeutics to Present at the 7th Annual Glioblastoma Drug Development Summit
February 11, 2026
 · 
6 min read
Press Releases
Stoke Therapeutics Announces First Patient Dosed in Phase 1 Study of STK-002, a Potential Disease-Modifying Medicine for the Treatment of Autosomal Dominant Optic Atrophy (ADOA)
February 11, 2026
 · 
8 min read
Press Releases
Ionis to hold fourth quarter and full year 2025 financial results webcast
February 11, 2026
 · 
1 min read
Press Releases
Precision BioSciences Receives U.S. FDA Clearance of Investigational New Drug Application for First-in-Class PBGENE-DMD for Treatment of Duchenne Muscular Dystrophy
February 11, 2026
 · 
9 min read
Press Releases
United Therapeutics Corporation to Report Fourth Quarter and Full Year 2025 Financial Results Before the Market Opens on Wednesday, February 25, 2026
February 11, 2026
 · 
2 min read
Press Releases
Vyome Files for VT-1953 Orphan Drug Status, Furthers Strategic Focus On VT-1953 Program Over the Next 6 Months
February 11, 2026
 · 
5 min read
Press Releases
KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Plus Paclitaxel ± Bevacizumab, Approved for Certain Adults with PD-L1+ (CPS ≥1) Platinum-Resistant Ovarian Carcinoma as Second or Third Line Treatment
February 11, 2026
 · 
19 min read
Press Releases
Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC)
February 11, 2026
 · 
3 min read
Press Releases
BeOne Medicines to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26
February 11, 2026
 · 
2 min read
Press Releases
Elevate Healthcare Marketing Expands Creative Leadership with Sean Conciatore
February 11, 2026
 · 
2 min read
Press Releases
Aspire Biopharma Announces $21 Million Private Placement by Select Investors, Strengthening Balance Sheet, Capital Position, and Fortifying Shareholder Equity to Meet Nasdaq Requirements
February 11, 2026
 · 
7 min read
Press Releases
Nuvectis Pharma, Inc. Reports 2025 Financial Results and Business Highlights
February 11, 2026
 · 
6 min read
Press Releases
BioRestorative Announces Positive Outcome from Type B Meeting with FDA
February 11, 2026
 · 
6 min read
Press Releases
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
February 11, 2026
 · 
11 min read
Press Releases
Labcorp Launches First FDA-Cleared Blood Test for Alzheimer’s Disease Assessment in Primary Care
February 11, 2026
 · 
3 min read
Load More